# Investigator Initiated Clinical Study to Explore the Efficacy and Safety of Human Placenta Hydrolysate in the Chronic Fatigue Patients

> **NCT01742013** · PHASE3 · COMPLETED · sponsor: **Ho Cheol Shin, M.D., Ph.D.** · enrollment: 78 (actual)

## Conditions studied

- Chronic Fatigue Syndrome
- Idiopathic Chronic Fatigue

## Interventions

- **DRUG:** GCJBP Laennec Inj.
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01742013
- **Lead sponsor:** Ho Cheol Shin, M.D., Ph.D.
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2013-08
- **Final completion:** 2013-09
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2013-09-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01742013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01742013, "Investigator Initiated Clinical Study to Explore the Efficacy and Safety of Human Placenta Hydrolysate in the Chronic Fatigue Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01742013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*